Skip to main content
Premium Trial:

Request an Annual Quote

German Scientists Pinpoint New Ovarian Cancer Biomarker

NEW YORK, Sept. 12 (GenomeWeb News) - Scientists at the German Cancer Research Center in Heidelberg, Germany published findings in this week's Lancet that described a protein biomarker for uterine and ovarian cancers with poor prognosis.

 

Peter Altevogt and others found the marker, L1 glycoprotein, using immunological and genotyping profiles of women with ovarian and uterine cancers. Presence of the marker indicates a poor prognosis.

 

Ovarian cancer has been the focus of several protein biomarker profiling studies over the past two years. See coverage in ProteoMonitor.

 

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.